Cited by 226Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsCardiac pacing and defibrillation studies

Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: an international, multicentre, randomised superiority trial

Macle, Laurent, Khairy, Paul, Weerasooriya, Rukshen, Novak, Paul, Verma, Atul, Willems, Stephan, Arentz, Thomas, Deisenhofer, Isabel +13 more·2015·The Lancet

Abstract

Background Catheter ablation is increasingly used to manage atrial fibrillation, but arrhythmia recurrences are common. Adenosine might identify pulmonary veins at risk of reconnection by unmasking dormant conduction, and thereby guide additional ablation to improve arrhythmia-free survival. We assessed whether adenosine-guided pulmonary vein isolation could prevent arrhythmia recurrence in patients undergoing radiofrequency catheter ablation for paroxysmal atrial fibrillation.Methods We did this randomised trial at 18 hospitals in Australia, Europe, and North America. We enrolled patients aged older than 18 years who had had at least three symptomatic atrial fibrillation episodes in the past 6 months, and for whom treatment with an antiarrhythmic drug failed. After pulmonary vein isolation, intravenous adenosine was administered. If dormant conduction was present, patients were randomly assigned (1:1) to additional adenosine-guided ablation to abolish dormant conduction or to no further ablation. If no dormant conduction was revealed, randomly selected patients were included in a registry. Patients were masked to treatment allocation and outcomes were assessed by a masked adjudicating committee. Patients were followed up for 1 year. The primary outcome was time to symptomatic atrial tachyarrhythmia after a single procedure in the intention-to-treat population. The trial is registered with ClinicalTrials.gov, number NCT01058980.Findings Adenosine unmasked dormant pulmonary vein conduction in 284 (53%) of 534 patients. 102 (69·4%) of 147 patients with additional adenosine-guided ablation were free from symptomatic atrial tachyarrhythmia compared with 58 (42·3%) of 137 patients with no further ablation, corresponding to an absolute risk reduction of 27·1% (95% CI 15·9-38·2; p<0·0001) and a hazard ratio of 0·44 (95% CI 0·31-0·64; p<0·0001). Of 115 patients without dormant pulmonary vein conduction, 64 (55·7%) remained free from symptomatic atrial tachyarrhythmia (p=0·0191 vs dormant conduction with no further ablation). Occurrences of serious adverse events were similar in each group. One death (massive stroke) was deemed probably related to ablation in a patient included in the registry.Interpretation Adenosine testing to identify and target dormant pulmonary vein conduction during catheter ablation of atrial fibrillation is a safe and highly effective strategy to improve arrhythmia-free survival in patients with paroxysmal atrial fibrillation. This approach should be considered for incorporation into routine clinical practice.Funding Canadian Institutes of Health Research, St Jude Medical, Biosense-Webster, and M Lachapelle (Montreal Heart Institute Foundation).

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(15)60026-5

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Macle, L., Khairy, P., Weerasooriya, R., Novak, P., Verma, A., Willems, S., Arentz, T., Deisenhofer, I., Veenhuyzen, G., Scavée, C., Jaïs, P., Puererfellner, H., Levesque, S., Andrade, J. G., Rivard, L., Guerra, P. G., Dubuc, M., Thibault, B., Talajic, M., Roy, D., & Nattel, S.
Affiliations
  • Montreal Heart Institute (CA)
  • The University of Western Australia (AU)
  • Royal Jubilee Hospital (CA)
  • Southlake Regional Health Center (CA)
  • Universität Hamburg (DE)
  • Universitäts-Herzzentrum Freiburg-Bad Krozingen (DE)
  • Deutsches Herzzentrum München (DE)
  • Libin Cardiovascular Institute of Alberta (CA)
  • Cliniques Universitaires Saint-Luc (BE)
Corresponding author
Macle, Laurent
Venue
The Lancet
Publisher
Elsevier BV
Published
2015-08
Volume
386
Issue
9994
Pages
672-679
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W1873062171
Cited by
226
References
30
Citations by year
2026: 5 · 2025: 12 · 2024: 10 · 2023: 11 · 2022: 11 · 2021: 16 · 2020: 30 · 2019: 26 · 2018: 20 · 2017: 43 · 2016: 31 · 2015: 11
FWCI
25.48
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
  • Digital Access to Libraries (submittedVersion)
  • FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
  • mediaTUM (Technical University of Munich) (submittedVersion)
Funders
  • St. Jude Medical
  • Canadian Institutes of Health Research
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Keywords
paroxysmal atrial fibrillation, adenosine, pulmonary vein isolation, radiofrequency catheter ablation, arrhythmia recurrence, arrhythmia-free survival, antiarrhythmic drug failure, atrial fibrillation recurrence prevention
MeSH terms
Adenosine, Anti-Arrhythmia Agents, Atrial Fibrillation, Female, Humans, Male, Middle Aged, Pulmonary Veins, Proportional Hazards Models, Treatment Outcome, Catheter Ablation, Secondary Prevention, Operative Time

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review